MD655Z - Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis - Google Patents
Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosisInfo
- Publication number
- MD655Z MD655Z MDS20120156A MDS20120156A MD655Z MD 655 Z MD655 Z MD 655Z MD S20120156 A MDS20120156 A MD S20120156A MD S20120156 A MDS20120156 A MD S20120156A MD 655 Z MD655 Z MD 655Z
- Authority
- MD
- Moldova
- Prior art keywords
- necrectomy
- patients
- hepatic cirrhosis
- wound hemostasis
- decompensated
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 206010053567 Coagulopathies Diseases 0.000 title abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract 2
- 230000023597 hemostasis Effects 0.000 title abstract 2
- 108090000190 Thrombin Proteins 0.000 abstract 2
- 229960004072 thrombin Drugs 0.000 abstract 2
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 229940105778 coagulation factor viii Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Abstract
The invention relates to medicine, in particular to methods of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis.According to the invention, the claimed method consists in that on the wound is applied a gauze bandage with an area of 100 cm2, in two layers, impregnated with a mixture containing cryoprecipitate and thrombin, taken in the ratio of 2:4 doses respectively, wherein one dose of cryoprecipitate contains the coagulation factor VIII in an amount of 100 IU and 250 mg of fibrinogen, and one dose of thrombin contains 125 IU.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20120156A MD655Z (en) | 2012-11-08 | 2012-11-08 | Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20120156A MD655Z (en) | 2012-11-08 | 2012-11-08 | Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD655Y MD655Y (en) | 2013-07-31 |
MD655Z true MD655Z (en) | 2014-03-31 |
Family
ID=48875338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDS20120156A MD655Z (en) | 2012-11-08 | 2012-11-08 | Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD655Z (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2328G2 (en) * | 2003-07-14 | 2004-07-31 | Константин ЦЫБЫРНЭ | Fibrinous adhesive and use thereof for endoscopic hemostasis of variceal hemorrhages in hepatic cirrhosis |
MD372Z (en) * | 2010-11-30 | 2011-12-31 | Георге АНГЕЛИЧ | Endoscopic method of hemostasis of bleeding ulcer in decompensated hepatic cirrhosis |
-
2012
- 2012-11-08 MD MDS20120156A patent/MD655Z/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD2328G2 (en) * | 2003-07-14 | 2004-07-31 | Константин ЦЫБЫРНЭ | Fibrinous adhesive and use thereof for endoscopic hemostasis of variceal hemorrhages in hepatic cirrhosis |
MD372Z (en) * | 2010-11-30 | 2011-12-31 | Георге АНГЕЛИЧ | Endoscopic method of hemostasis of bleeding ulcer in decompensated hepatic cirrhosis |
Non-Patent Citations (2)
Title |
---|
Апарцин К. Хирургия тяжелых гнойных процесcов. Под ред. Григорьева Б. Г. Новосибирск, 2003, p. 346 * |
Кузин М., Костиченюк Б. Раны и раневая инфекция. Москва, 1990, p. 591 * |
Also Published As
Publication number | Publication date |
---|---|
MD655Y (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008103345A3 (en) | Hemostatic compositions and therapeutic regimens | |
BR112012016633A2 (en) | dry powder pharmaceutical composition and wound treatment method. | |
BR112013032829A2 (en) | absorbent article with a waistband that has consolidation | |
PH12016500619A1 (en) | Dry powder inhaler | |
GT201300235A (en) | USE OF 2,3-DIHYDROIMIDAZO (1,2-C) SUBSTITUTED KINAZOLINS | |
EP2547355A4 (en) | Tfpi inhibitors and methods of use | |
MX2013014543A (en) | Treatment of coagulation disease by administration of recombinant vwf. | |
BR112013022217A8 (en) | pharmaceutical composition, method of preventive treatment of a hemorrhagic syndrome in a patient with hemophilia a or b and method of treatment of a hemorrhagic accident in a patient with hemophilia a or b | |
GB2567790A (en) | Wound covering with haemostatic action and the method of its creation | |
BR112015013374A2 (en) | hemostatic glove device and method for using it | |
TR201903940T4 (en) | Dressing with extended release active ingredient. | |
PH12014501579A1 (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers | |
NZ583803A (en) | Agents with angiogenic and wound healing activity | |
NZ757595A (en) | Method of treatment of hypoxia inducible factor (hif)-related conditions | |
MX343784B (en) | Factor ii and fibrinogen for treatment of haemostatic disorders. | |
MD655Z (en) | Method of wound hemostasis after necrectomy in patients with severe coagulopathies against decompensated hepatic cirrhosis | |
CN202136481U (en) | Propolis band-aid | |
Fogarty et al. | How we treat: patients with haemophilia undergoing screening colonoscopy. | |
CN203122512U (en) | Medical tourniquet | |
MX2016013281A (en) | Half-life extended factor fviia protein for prevention and treatment of bleeding and dosing regimens therefor. | |
Herzog et al. | Four-factor prothrombin complex concentrate (4-PCC) effectively reverses edoxaban induced bleeding in a rabbit model of acute injury | |
UA92535U (en) | Method for preventing intraoperative and early postoperative intrapleural bleeding following surgery for tuberculosis of lungs and pleura | |
MX361222B (en) | Sealant compositions. | |
WO2015028905A3 (en) | Latex dipped articles embedded with natural herbs | |
JP2016510315A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG9Y | Short term patent issued | ||
KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
MM4Y | Short-term patent definitely lapsed due to non-payment of fees |